In 2024, 94 per cent of obese patients in the 7MM (US, 5EU, and Japan) are using methods such as lifestyle intervention, diet, and exercise to manage weight, as shown in Figure 1
Aggressive shaking can damage the peptide structure and reduce potency
The most recent addition to the family of medicines that act on GLP-1 receptors has been semaglutide, which has been licensed to both manage type 2 diabetes (Ozempic) and obesity (Wegovy)
It tends to cluster in the first 48 hours after each injection and at the time of dose increases, then settles into the background for most people once they are at a stable dose
I have been using terepizide from Citizen Meds for four months now
Following on from my previous blog regarding the B12 OTC Petition and the future Westminster Hall debate which my MP Jane Hunt will apply for some of you kind people have asked your MP to join Jane and also make supporting speeches